Current Report Filing (8-k)
October 24 2016 - 2:53PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): October 19, 2016
Bio-Matrix
Scientific Group, Inc.
(Exact
Name of Company as Specified in Charter)
Commission File
Number: 0-32201
|
|
|
|
Delaware
|
33-0824714
|
|
(State or Other Jurisdiction of
Incorporation)
|
(IRS Employer Identification
Number)
|
4700
Spring Street, St 304
La
Mesa California, 91942
(Address
of Principal Executive Offices, Zip Code)
Company’s
telephone number, including area code:
(619) 702-1404
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 4.01 CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT.
(a) On September 13, 2016 Seale and Beers, CPAs , the
independent registered public accounting firm for Bio Matrix Scientific Group, Inc. , informed the Company that Beers was in the
process of being acquired by AMC Auditing. On October 19, 2016 the Board of Directors of Bio Matrix Scientific Group, Inc. (the
“Registrant” or the “Company”) approved of the dismissal of Seale and Beers, CPAs (“Beers”)
as the Registrant’s independent registered public accounting firm.
Beers’ report of the Company’s financial
statements for the fiscal years ended September 30, 2015 and September 30, 2014 did not contain any adverse opinion or disclaimer
of opinion, nor was modified as to uncertainty, audit scope, or accounting principles. The audit reports prepared by Beers for
the fiscal years ending September 30, 2015 and September 30, 2014 contained a paragraph with respect to the Company's ability to
continue as a going concern.
During the Registrant's two most recent fiscal years
and the subsequent interim periods thereto there were no disagreements with Beers, whether or not resolved, on any matter of accounting
principles or practices, financial statement disclosure, or auditing scope or procedure, which, if not resolved to Beers’
satisfaction, would have caused it to make reference to the subject matter of the disagreement in connection with its report on
the Registrant's financial statements.
The Company provided Beers with a copy of this disclosure
set forth under this Item 4.01 and has requested Beers to furnish a letter addressed to the Securities & Exchange Commission
stating whether or not Beers agrees with the above statements.
A copy of this letter from Beers is attached hereto
as Exhibit 16.1.
(b) On October 19, 2016, the Board of Directors
of the Registrant, acting as the Registrant's Audit Committee, approved the engagement of AMC Auditing as its independent auditor.
On same date, October 19, 2016, the accounting firm of AMC Auditing was engaged as the Registrant's new independent registered
public accounting firm.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
Exhibit 16.1 Letter from Seale and
Beers, CPAs
SIGNATURE
Pursuant to
the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
|
BIO MATRIX SCIENTIFIC GROUP, INC.
|
|
|
|
|
Dated: October 20, 2016
|
By:
/s/ David Koos
|
|
|
David Koos
|
|
|
Chief Executive Officer
|